References
- Quesada L, Gomila I, Yates C, et al. Elimination half-life of alpha-pyrrolidinovalerophenone in an acute non-fatal intoxication. Clin Toxicol. 2016;54:531–532.
- Umebachi R, Aoki H, Sugita M, et al. Clinical characteristics of a-pyrrolidinovalerophenone (α-PVP) poisoning. Clin Toxicol. 2016;54:563–567.
- Beck O, Franzén L, Bäckberg M, et al. Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project. Clin Toxicol. 2016;54:568.
- Ford LT, Berg JD. Analysis of legal high materials by UPLC-MS/TOF as part of a toxicology vigilance system. What are the most popular novel psychoactive substances in the UK? Ann Clin Biochem. 2016;53:640–646.
- Glennon RA, Young R. Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP). Brain Res Bull. 2016;126:111–126.